SCHEMBL753675

SCHEMBL753675

Cc1[c]cccc1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
ALOX15 P16050 1/20 0.48
KDM4E B2RXH2 4/20 0.45
HPGD P15428 4/20 0.45
HSD17B10 Q99714 3/20 0.45
CA12 O43570 3/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA4 P22748 3/20 0.41
CA7 P43166 3/20 0.41
CA9 Q16790 3/20 0.41
HMGB1 P09429 2/20 0.41
NAPRT Q6XQN6 2/20 0.41
CA6 P23280 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CA14 Q9ULX7 1/20 0.41
MYC P01106 4/20 0.41
AKR1C3 P42330 2/20 0.41
NR4A1 P22736 1/20 0.41
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4372772 0.83 PBRM1 (0.37) ALDH1A1ALOX15KDM4EHPGDHSD17B10
SCHEMBL1893396 0.81 PARP1 (0.44) ALDH1A1KDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL6160784 0.78 GAA (0.47) ALOX15KDM4EHSD17B10CA12CA1
SCHEMBL10412258 0.78 HSP90AB1 (0.39) ALDH1A1KDM4EHSD17B10SMN1; SMN2MAPT
SCHEMBL1098615 0.78 TSHR (0.50) ALDH1A1ALOX15KDM4EHSD17B10CA1
SCHEMBL4024749 0.78 KMT2A (0.46) ALDH1A1KDM4EHPGDSMN1; SMN2MAPT
SCHEMBL1100763 0.78 GAA (0.48) HPGDHDAC8POLB
SCHEMBL3844824 0.76 ALDH1A1 (0.50) ALDH1A1ALOX15KDM4EHPGDHSD17B10
SCHEMBL160051 0.76 ALDH1A1 (0.50) ALDH1A1ALOX15KDM4EHPGDHSD17B10
SCHEMBL12521035 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430013-A1 HETEROARYL COMPOUNDS AS PIKK INHIBITORS Amgen, Inc (US) 2012-03-21 EP claimed
WO-2010132598-A1 HETEROARYL COMPOUNDS AS PIKK INHIBITORS AMGEN INC. (US) 2010-11-18 WO claimed
EP-1962846-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-09-03 EP claimed
US-20070161674-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. 2007-07-12 US claimed
WO-2007059323-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-24 WO claimed
US-7160933-B2 Image quality and durability; scratch and smudge resistance; water, humectant and particles comprised of water insoluble dye and polymer phase associated with costabilizer EASTMAN KODAK COMPANY (US) 2007-01-09 US claimed
US-20060049052-A1 Ampholytic buffer having high buffering capacity and high conductivity in isoelectric form THE TEXAS A&M UNIVERSITY SYSTEM (US) 2006-03-09 US claimed
US-20040186198-A1 Stable ink jet ink composition and printing method EASTMAN KODAK COMPANY 2004-09-23 US claimed
EP-0277725-A2 4-Aryl-N-[2-(dialkylamino and heterocyclicamino) alkyl]-1-piperazinecarboxamides and their use as anti allergy agents A.H. ROBINS COMPANY, INCORPORATED (US) 1988-08-10 EP claimed
EP-4373865-A1 CATALYTIC HYDROGENOLYSIS OF A POLYMER Northwestern University (US) 2024-05-29 EP disclosed
CN-113896607-B Olefin oligomerization process using a catalyst comprising a chromium complex having a phosphacycle-containing ligand 陶氏环球技术有限责任公司 2024-04-16 CN disclosed
CN-117651723-A Catalytic hydrogenolysis of polymers 西北大学 2024-03-05 CN disclosed
US-11896965-B2 Chromium complex and catalyst therefrom DOW GLOBAL TECHNOLOGIES LLC (US) 2024-02-13 US disclosed
US-20230112954-A1 CHROMIUM COMPLEX AND CATALYST THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2023-04-13 US disclosed
EP-0423742-A2 Silver halide color reversal photographic photosensitive material FUJI PHOTO FILM CO., LTD. (JP) 1991-04-24 EP disclosed
EP-0423693-A2 Silver halide color photographic material FUJI PHOTO FILM CO., LTD. (JP) 1991-04-24 EP disclosed
EP-0391405-A2 Silver halide photographic material and method for processing thereof FUJI PHOTO FILM CO., LTD. (JP) 1990-10-10 EP disclosed
EP-0337490-A2 Silver halide light-sensitive photographic material Fuji Photo Film Co., Ltd. (JP) 1989-10-18 EP disclosed
EP-0334593-A1 Chiral azetidinone epoxides THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1989-09-27 EP disclosed
US-4317946-A IN THE PRESENCE OF A RUTHENIUM CATALYST THE HALCON SD GROUP, INC. (US) 1982-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230112954-A1 CHROMIUM COMPLEX AND CATALYST THEREFROM OXER1, LIG1, PICALM ALDH1A1 4013/4885ALOX15 19/4885KDM4E 2781/4885
US-20060049052-A1 Ampholytic buffer having high buffering capacity and high conductivity in isoelectric form ALPP, CA2, CA1 ALDH1A1 4582/4885ALOX15 4140/4885KDM4E 4802/4885
US-11896965-B2 Chromium complex and catalyst therefrom OXER1, LIG1, PICALM ALDH1A1 4013/4885ALOX15 19/4885KDM4E 2781/4885
US-20070161674-A1 Certain chemical entities, compositions, and methods TP53, VHL, RB1 ALDH1A1 258/4885ALOX15 766/4885KDM4E 4110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.